AICART	Aminoimidazole carboxamide ribonucleotide transformylase
ALK	Anaplastic lymphoma kinase
AQ	anthraquinone
ARS	Artesunate
BCR	Breakpoint cluster region
BRAF	v-raf murine sarcoma viral oncogene homolog B1
CA-4	Combretasin A-4
CDK	Cyclin dependent kinase
CNS	Central Nervous System
CSF-1	Colony-stimulating factor
DENV-2	Dengue virus serotype 2
DHA	Dihydroartemisinin
DLC	Drug loading content
DLE	Drug-loading efficiency
DMEM	Dulbecco’s Modified Eagle Medium
DOX	Doxorubicin
DPPH	2,2-diphenylpicrylhydrazyl
EAC	Ehrlich Ascites Carcinoma
EC50	Half maximal effective concentration
EGFR	Epidermal growth factor receptor
EMT	Epithelial Mesenchymal transition
ERK	Extracellular signal-regulated kinase
FLT3	Fms-like tyrosine kinase
GI50	Half maximal Growth Inhibition
HDAC	Histone deacetylases
HER	Human epidermal growth factor receptor
HetQ	heterocycle-fused quinone
IC50	Half maximal Inhibitory concentration
JAK2	Janus kinase 2
KDR	Kinase insert domain receptor
LC50	Half maximal Lethal concentration
MEK	Mitogen-activated protein kinase
MG-MID	Mean graph midpoint
MTT	3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide
NCI	National Cancer Institute
ND	Not Defined
NQ	Naphthoquinone
NSCLC	Non-small cell lung cancer
P13K	Phosphoinositide3-kinase
PBD	Pyrrolo-benzodiazepines
PGDFR	Platelet-derived growth factor
Raf	Rapidly accelerated fibrosarcoma
Ras	Rat Sarcoma
ROS	Reactive Oxygen Species
SAHA	standard hydroxamic acid
SRB	Sulforhodamine B
TKi	Tyrosine kinase inhibitor
TRK	Tropomyosin Receptor Kinase
VEGFR	vascular endothelial growth factor receptor
XPO1	Exportin 1